Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian patients with hormoneresistant prostate cancer.

Zdroj: International Journal of Clinical Pharmacology & Therapeutics; 2010, Vol. 48 Issue 11, p708-717, 10p
Databáze: Complementary Index